(Reuters) - But the Indianapolis drug maker said its net profit fell to $664 million, or 61 cents per share from $822 million, or 76 cents per share, a year earlier.
Excluding charges, including those related to acquisitions of Hypnion Inc. and Ivy Animal Health, Lilly earned 90 cents per share. Analysts on average expected 82 cents per share, according to Reuters Estimates.
Read more at Reuters.com Market News
Excluding charges, including those related to acquisitions of Hypnion Inc. and Ivy Animal Health, Lilly earned 90 cents per share. Analysts on average expected 82 cents per share, according to Reuters Estimates.
Read more at Reuters.com Market News
No comments:
Post a Comment